As of Mar 23
| -0.05 / -1.64%|
The 5 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +133.33% increase from the last price of 3.00.
The current consensus among 6 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.